Anaphylaxis to isosulfan blue

Scot A. Laurie, David A. Khan, Rebecca S. Gruchalla, George Peters

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Isosulfan blue 1% is a dye used in medical procedures such as lymphangiography and sentinel lymph node biopsy. Anaphylactic reactions to this dye have been rarely reported. Objective: We are reporting two patients who experienced anaphylaxis after subcutaneous administration of isosulfan blue. Methods: Two female patients with breast cancer were evaluated by our allergy service after suspected intraoperative anaphylactic episodes during sentinel lymph node biopsies in which they had received isosulfan blue 1% for the purpose of visualization of the lymph vessels. In the first case, the patient suffered hypotension and hypoxia requiring intubation. In the second case, the patient suffered prolonged hypotension. Both patients recovered without sequelae. The patients were seen in our clinic, and skin tests were performed to isosulfan blue in addition to other agents the patients had received during anesthesia. Results: In both cases, the patients demonstrated positive skin tests to isosulfan blue. Neither patient had positive skin tests to any other agent used for skin testing. Isosulfan blue skin tests were performed in nine control subjects and all skin tests in the control subjects were negative. Conclusions: Isosulfan blue may be a cause of anaphylactic reactions and this seems to be an immunoglobulin E-mediated event as confirmed by positive skin tests.

Original languageEnglish (US)
Pages (from-to)64-66
Number of pages3
JournalAnnals of Allergy, Asthma and Immunology
Volume88
Issue number1
StatePublished - 2002

Fingerprint

Anaphylaxis
Skin Tests
Sentinel Lymph Node Biopsy
Hypotension
Coloring Agents
Lymphography
iso-sulfan blue
Proxy
Lymph
Intubation
Immunoglobulin E
Hypersensitivity
Anesthesia
Breast Neoplasms
Skin

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Anaphylaxis to isosulfan blue. / Laurie, Scot A.; Khan, David A.; Gruchalla, Rebecca S.; Peters, George.

In: Annals of Allergy, Asthma and Immunology, Vol. 88, No. 1, 2002, p. 64-66.

Research output: Contribution to journalArticle

Laurie, Scot A. ; Khan, David A. ; Gruchalla, Rebecca S. ; Peters, George. / Anaphylaxis to isosulfan blue. In: Annals of Allergy, Asthma and Immunology. 2002 ; Vol. 88, No. 1. pp. 64-66.
@article{7a9e341fbca84968bd0c84311175528a,
title = "Anaphylaxis to isosulfan blue",
abstract = "Background: Isosulfan blue 1{\%} is a dye used in medical procedures such as lymphangiography and sentinel lymph node biopsy. Anaphylactic reactions to this dye have been rarely reported. Objective: We are reporting two patients who experienced anaphylaxis after subcutaneous administration of isosulfan blue. Methods: Two female patients with breast cancer were evaluated by our allergy service after suspected intraoperative anaphylactic episodes during sentinel lymph node biopsies in which they had received isosulfan blue 1{\%} for the purpose of visualization of the lymph vessels. In the first case, the patient suffered hypotension and hypoxia requiring intubation. In the second case, the patient suffered prolonged hypotension. Both patients recovered without sequelae. The patients were seen in our clinic, and skin tests were performed to isosulfan blue in addition to other agents the patients had received during anesthesia. Results: In both cases, the patients demonstrated positive skin tests to isosulfan blue. Neither patient had positive skin tests to any other agent used for skin testing. Isosulfan blue skin tests were performed in nine control subjects and all skin tests in the control subjects were negative. Conclusions: Isosulfan blue may be a cause of anaphylactic reactions and this seems to be an immunoglobulin E-mediated event as confirmed by positive skin tests.",
author = "Laurie, {Scot A.} and Khan, {David A.} and Gruchalla, {Rebecca S.} and George Peters",
year = "2002",
language = "English (US)",
volume = "88",
pages = "64--66",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "1",

}

TY - JOUR

T1 - Anaphylaxis to isosulfan blue

AU - Laurie, Scot A.

AU - Khan, David A.

AU - Gruchalla, Rebecca S.

AU - Peters, George

PY - 2002

Y1 - 2002

N2 - Background: Isosulfan blue 1% is a dye used in medical procedures such as lymphangiography and sentinel lymph node biopsy. Anaphylactic reactions to this dye have been rarely reported. Objective: We are reporting two patients who experienced anaphylaxis after subcutaneous administration of isosulfan blue. Methods: Two female patients with breast cancer were evaluated by our allergy service after suspected intraoperative anaphylactic episodes during sentinel lymph node biopsies in which they had received isosulfan blue 1% for the purpose of visualization of the lymph vessels. In the first case, the patient suffered hypotension and hypoxia requiring intubation. In the second case, the patient suffered prolonged hypotension. Both patients recovered without sequelae. The patients were seen in our clinic, and skin tests were performed to isosulfan blue in addition to other agents the patients had received during anesthesia. Results: In both cases, the patients demonstrated positive skin tests to isosulfan blue. Neither patient had positive skin tests to any other agent used for skin testing. Isosulfan blue skin tests were performed in nine control subjects and all skin tests in the control subjects were negative. Conclusions: Isosulfan blue may be a cause of anaphylactic reactions and this seems to be an immunoglobulin E-mediated event as confirmed by positive skin tests.

AB - Background: Isosulfan blue 1% is a dye used in medical procedures such as lymphangiography and sentinel lymph node biopsy. Anaphylactic reactions to this dye have been rarely reported. Objective: We are reporting two patients who experienced anaphylaxis after subcutaneous administration of isosulfan blue. Methods: Two female patients with breast cancer were evaluated by our allergy service after suspected intraoperative anaphylactic episodes during sentinel lymph node biopsies in which they had received isosulfan blue 1% for the purpose of visualization of the lymph vessels. In the first case, the patient suffered hypotension and hypoxia requiring intubation. In the second case, the patient suffered prolonged hypotension. Both patients recovered without sequelae. The patients were seen in our clinic, and skin tests were performed to isosulfan blue in addition to other agents the patients had received during anesthesia. Results: In both cases, the patients demonstrated positive skin tests to isosulfan blue. Neither patient had positive skin tests to any other agent used for skin testing. Isosulfan blue skin tests were performed in nine control subjects and all skin tests in the control subjects were negative. Conclusions: Isosulfan blue may be a cause of anaphylactic reactions and this seems to be an immunoglobulin E-mediated event as confirmed by positive skin tests.

UR - http://www.scopus.com/inward/record.url?scp=0036143660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036143660&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 64

EP - 66

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 1

ER -